Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2021 Oct 15;89(11):e00387-21. doi: 10.1128/IAI.00387-21

Biofilm Formation and Virulence of Shigella flexneri Are Modulated by pH of Gastrointestinal Tract

I-Ling Chiang a, Yi Wang a, Satoru Fujii b, Brian D Muegge c,d, Qiuhe Lu b, Phillip I Tarr e,f, Thaddeus S Stappenbeck b,
Editor: Igor E Brodskyg
PMCID: PMC8519285  PMID: 34424745

ABSTRACT

Shigella infection remains a public health problem in much of the world. Classic models of Shigella pathogenesis suggest that microfold epithelial cells in the small intestine are the preferred initial site of invasion. However, recent evidence supports an alternative model in which Shigella primarily infects a much wider range of epithelial cells that reside primarily in the colon. Here, we investigated whether the luminal pH difference between the small intestine and the colon could provide evidence in support of either model of Shigella flexneri pathogenesis. Because virulence factors culminating in cellular invasion are linked to biofilms in S. flexneri, we examined the effect of pH on the ability of S. flexneri to form and maintain adherent biofilms induced by deoxycholate. We showed that a basic pH (as expected in the small intestine) inhibited formation of biofilms and dispersed preassembled mature biofilms, while an acidic pH (similar to the colonic environment) did not permit either of these effects. To further elucidate this phenomenon at the molecular level, we probed the transcriptomes of biofilms and S. flexneri grown under different pH conditions. We identified specific amino acid (cysteine and arginine) metabolic pathways that were enriched in the bacteria that formed the biofilms but decreased when the pH increased. We then utilized a type III secretion system reporter strain to show that increasing pH reduced deoxycholate-induced virulence of S. flexneri in a dose-dependent manner. Taken together, these experiments support a model in which Shigella infection is favored in the colon because of the local pH differences in these organs.

KEYWORDS: Shigella, bile acids, biofilm, colon, pH

INTRODUCTION

Shigella spp. are Gram-negative pathogens that cause approximately 5 to 15% of the diarrheal burden in the world (1, 2). Infection can have serious consequences, as Shigella infection contributes to ∼200,000 deaths per year, mostly among children (2). Shigella is most efficiently transmitted from human to human by a fecal-oral route and can invade intestinal epithelial cells (3, 4). Despite the morbidity and deaths resulting from Shigella infections, clinically termed shigellosis, there is not an effective vaccine for this agent, and we do not fully understand the mechanism by which Shigella infects the gut mucosa (5).

One major limitation to understanding Shigella pathogenesis is that humans are the main reservoir for this microbe. Primates can be infected, but establishment of other in vivo animal models that recapitulate the phenotypes of enteric invasion has been challenging (6). Data from infection of ex vivo ligated rabbit ileal loops suggest that Shigella organisms are phagocytosed by specialized epithelial microfold (“M”) cells that most prominently overlie organized gut-associated lymphoid tissue (GALT). These M cells facilitate bacterial translocation to immune cells beneath their basolateral surface (7). One shortcoming of this model is that in humans M cells are primarily found in ileal Peyer’s patches of the small intestine, whereas the manifestations of Shigella infection are predominantly related to the colon (1, 8). Physiological and pathological studies of Shigella infections in humans and rhesus monkeys, respectively, demonstrate that this genus primarily invades and damages colonic epithelium in areas not necessarily associated with GALT and minimally affects the small intestine (9, 10). In vitro, however, primary gut epithelium infection studies demonstrate that Shigella can invade epithelial cells of small and large intestines (11). Based on these discrepancies between in vivo and in vitro observations, we hypothesize that differences between the luminal environments of small intestine and colon account for the preferential tropism of Shigella for the colon.

Bile is one important luminal factor that enteric pathogens encounter during their colonization and invasion of the gut wall. Bile is a heterogeneous mixture of primary and secondary bile salts, cholesterol, phospholipids, and bilirubin that facilitates the digestion of fat in the small intestine (12). Pathogenic bacteria, including Escherichia coli, Vibrio cholerae, Campylobacter jejuni, and Shigella, have evolved mechanisms to resist the antimicrobial properties of bile, and some even utilize bile as a signal to regulate virulence (13). Relevant here, upon exposure to bile salts, Shigella increases secretion of virulence factors, thus increasing adherence to and invasion of host cells (14, 15). Additionally, long-term bile salt exposure in vitro induces Shigella biofilm formation, a phenomenon that is also observed when V. cholerae encounters bile salts (15, 16). Although a large portion of bile salts are absorbed in the ileum, approximately 400 to 800 mg of bile salts enter the colon daily (17). Thus, despite its importance in increasing pathogenic potency, it is unlikely that bile salts are the sole factor explaining the preferential colonic infection by Shigella.

Concurrent with the inflow of bile into the small intestine, however, is the influx of bicarbonate (HCO3), the physiological base used to buffer acidic contents from the stomach, creating an alkaline luminal environment in the distal small intestine (the mean pH is 7.7, with a range of mostly pH 7.4 to 8.0) (18, 19). In contrast, the colonic lumen is typically more acidic (the average pH is 6.4; the variability is much greater than that in the distal small intestine, with a range of pH 5.0 to 8.0) (18, 19). Interestingly, bicarbonate modulates virulence factors, toxin production, and biofilm formation in V. cholerae (16, 20, 21). However, scant data exist regarding interactions between bicarbonate and Shigella. Given the pH differences between the distal small intestine and the colon, as well as the role of pH in regulating the pathogenic activity of Vibrio cholerae, we hypothesized that pH may play a role in regulating bile salt-dependent virulence of Shigella and its preferential pathogenesis in the colon. We demonstrate that alkalization attenuates Shigella biofilm formation, disperses formed biofilm, does not kill the pathogen, and downregulates transcription of bacterial virulence loci, with a net negative effect on pathogenesis.

In this study, we utilized previously established biofilm formation methods to test whether deoxycholate-induced biofilms of Shigella flexneri could form under various pH conditions (15). We demonstrated that more basic pH levels, as observed in the small intestine, attenuated biofilm formation without causing bacterial cell death. Additionally, we showed that basic pH conditions dispersed mature biofilms. RNA sequencing of S. flexneri under various pH conditions showed differences in transcriptional profiles of bacteria grown in deoxycholate with or without NaOH. Using a type III secretion system (T3SS) reporter strain of Shigella, we demonstrated that increasing pH could also downregulate virulence. Collectively, these studies demonstrate that basic conditions, as found in the lumen of the small intestine, are not favorable for S. flexneri pathogenesis, and they provide new mechanistic insights into shigellosis pathogenesis.

RESULTS

Basic conditions attenuate deoxycholate-induced biofilm formation.

Sodium deoxycholate (NaDCA), a secondary bile salt found in the small and large intestines, enhances secretion of S. flexneri virulence factors in planktonic culture (14). We initially tested whether this bile acid affected the ability of S. flexneri to form biofilms in vitro (Fig. 1A). To optimize conditions to produce biofilms, we grew S. flexneri in tryptic soy broth (TSB) supplemented with various concentrations of NaDCA, and then we measured the opacity of biofilms by the optical density at 600 nm (OD600). Incubation of S. flexneri with 0.05% NaDCA stimulated formation of biofilms that approached 50% of maximum opacity and was thus suitable for testing the effects of external factors on biofilm formation (Fig. 1B).

FIG 1.

FIG 1

Experimental procedure utilized in this study. (A) Diagram showing the two phases of bacterial growth after overnight incubation in TSB with NaDCA at 37°C. (B) The opacity of Shigella biofilms induced by increased percentages of NaDCA for 24 h at 37°C. Note that 0.05% NaDCA induced biofilms that were approximately 50% of the maximal opacity and were selected for subsequent experiments (arrowhead). (C) Schematic diagram of assays with Shigella biofilms grown in 0.05% NaDCA and exposed to various pH values. Biofilms were assayed for density (biofilm OD600), viability (MTT assay), planktonic cell density (planktonic cell OD600), and bacterial counts (CFU per milliliter) as described in the text.

We hypothesized that alterations of extracellular pH would impact biofilm formation, because the pH of the intestinal lumen varies along its length (18). To simulate the basic conditions found in the small intestine, we adjusted the pH of the TSB containing 0.05% NaDCA with increasing concentrations of NaOH. We characterized the resulting biofilms by OD600 to measure opacity, by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay to assess microbial viability, and by CFU to quantify the number of planktonic bacteria in the medium that were not incorporated into the biofilm (Fig. 1C and Fig. 2A and B). Increasing NaOH in the TSB decreased biofilm opacity (Fig. 2C) in a dose-dependent manner, with almost complete loss of biofilm at 20 mM (Fig. 2E). Importantly, the pH values that correspond to 5 and 10 mM are in the range of what is found in the human distal small intestine (19). MTT and crystal violet assays corroborated the reduction in biofilm formation with NaOH treatment (Fig. 2D; also see Fig. S1A and B in the supplemental material). Importantly, the attenuation of biofilm formation by increased pH did not appear to be secondary to enhanced bacterial killing by NaOH. In fact, the planktonic phase of S. flexneri that was maintained apically of the biofilm was enhanced by increased pH, as measured by OD600 and CFU per milliliter (Fig. 2F; also see Fig. S1C). Our interpretation of these data is that there was an increased influx of bacteria into the planktonic phase as the biofilm was disassembled under basic conditions.

FIG 2.

FIG 2

Effects of increased pH on formation of deoxycholate-induced biofilms. (A) Diagram describing the experimental steps for testing the effects of NaOH on biofilm formation induced by NaDCA. (B) Table showing the corresponding pH values when increasing concentrations of NaOH were added to TSB containing 0.05% NaDCA. (C and D) Opacity (measured as OD600) (C) and viability (measured with the MTT assay) (D) of biofilms induced by 0.05% NaDCA with increasing concentrations of NaOH, after 24 h at 37°C (n ≥ 3 independent experiments). (E) Representative images of biofilms induced by NaDCA with or without 20 mM NaOH. (F) Growth curves of the planktonic Shigella (measured as OD600) growing above NaDCA-induced biofilms with increasing NaOH concentrations (n = 3 independent experiments). Statistical significance was measured at the endpoint. (G and H) Biofilm viability (G) and planktonic growth (H) with or without 0.3% NaHCO3 (n = 2 independent experiments). (I) Biofilm viability with or without 20 mM NaCl (as a control for ionic strength) (n = 2 independent experiments). All bar graphs were plotted as mean and standard deviation. Statistical significance was determined by Student’s t tests with P values of <0.05. **, significant with two-tailed Student's t test. NS, not significant.

Taken together, these data support the hypothesis that a basic pH attenuates NaDCA-induced biofilm formation in S. flexneri and this effect occurs in a range of pH values that are similar to those in the human small intestinal lumen (Fig. 2B). To further test whether a basic environment, as found in the small intestine, plays a role in decreasing deoxycholate-induced biofilm formation, we repeated our assay with NaHCO3, the physiological agent responsible for modulating pH in the small intestine, and we confirmed that a physiologically relevant bicarbonate concentration (0.3%) (22) could prevent biofilm formation (Fig. 2G and H). To control for the possible effects induced by changes in ionic strength, we tested NaCl at the same concentrations and confirmed that NaCl did not affect biofilm formation (Fig. 2I).

Acidic conditions do not affect biofilm formation but decrease the viability of S. flexneri.

To test whether the acidic pH that S. flexneri encounters in the large intestine influences biofilm formation, we supplemented TSB with increasing concentrations of HCl (see Fig. S1D). In contrast to the increased biofilm density observed under basic conditions, we found that acidic pH did not significantly change biofilm opacity (see Fig. S1E). Despite the presence of biofilms under all acidic conditions, the MTT and crystal violet assays showed diminished activity, indicating that either the metabolism or the number of bacteria surviving in the biofilms was decreased as the concentration of HCl was increased (see Fig. S1F and G). The number of planktonic bacteria growing in the medium above the biofilm was also decreased with HCl addition (see Fig. S1G and I). Our inability to reduce biofilm assembly and formation under acidic conditions despite decreased viability and/or metabolism for S. flexneri prompts consideration of a model in which S. flexneri biofilms are better supported in the colon, where the acidic milieu does not prevent bile salt-induced biofilm formation.

Environmental pH modulates dispersal of mature S. flexneri biofilms.

We next asked whether alkalinity affects biofilms that are already assembled and mature. First, we induced biofilm formation with NaDCA, allowed the biofilm to mature for 24 h, and then exchanged the growth medium to TSB without NaDCA over a range of NaOH concentrations (Fig. 3A). We found that the addition of 2.5, 5, or 10 mM NaOH did not significantly affect biofilm opacity, although there was a trend toward reduction. Treatment with 20 mM NaOH fully dispersed the mature biofilm, as indicated by decreased opacity (Fig. 3B). The effect of basic pH on biofilm dispersal was less than its effect on biofilm formation. These data were further supported by the MTT assay (Fig. 3C). These data suggest that the disruptive effects of NaOH on S. flexneri biofilms were caused not by deprotonation of deoxycholate but rather by direct effects on the pathogen. We found that acidic environments did not significantly disperse mature biofilms or reduce bacterial viability (see Fig. S2A and B).

FIG 3.

FIG 3

Dispersal of biofilms modulated by increased pH. (A) Illustration of the experimental procedures for testing the effects of NaOH on biofilm dispersion and disassembly. (B and C) Opacity (B) and viability (C) of preformed biofilms incubated with increasing concentrations of NaOH for 24 h (n = 3 independent experiments). All bar graphs were plotted as mean and standard deviation. Statistical significance was determined by Student’s t tests with P values of <0.05. **, significant with two-tailed Student's t test.

RNA sequencing demonstrates that basic conditions attenuate a biofilm-associated transcriptomic program.

To gain additional insight into how pH affects S. flexneri biofilm formation, we performed RNA sequencing to determine the transcriptomic alterations in S. flexneri caused by pH modulation. We performed this analysis using (i) planktonic cultures in TSB only, (ii) biofilms in TSB plus 0.05% NaDCA, and (iii) planktonic cultures in TSB plus 0.05% NaDCA plus 20 mM NaOH. A global view of the transcriptional profiles of these experimental groups, as shown by principal-component analysis (PCA) plot, indicated that there were indeed transcriptional differences among the experimental groups (see Fig. S3A).

To identify gene signatures that were associated with biofilm formation, we first compared the mRNA transcriptomic profiles between the deoxycholate-induced biofilm and planktonic S. flexneri grown in TSB only. Pathway analysis (Database for Annotation, Visualizations and Integrated Discovery [DAVID] v6.7) of genes upregulated in the biofilm showed an enrichment of ABC transporter genes, as well as genes involved in arginine and sulfur metabolism (Fig. 4A). Interestingly, arginine and cysteine metabolic pathways have been reported to be important in biofilm formation in other bacterial species (23, 24). We next compared the biofilm cultures grown with and without 20 mM NaOH. Pathway analysis demonstrated that NaOH repressed deoxycholate-induced biofilm enrichment of ABC transporter, arginine metabolism, and sulfur metabolism genes (Fig. 4B). Heatmap analysis of representative genes from these pathways further supported specific increases in gene transcripts only in the presence of NaDCA (Fig. 4C). Quantitative PCR (qPCR) analysis of candidate genes involved in arginine and cysteine metabolism confirmed the RNA sequencing results (see Fig. S3B). Taken together, these data demonstrated that basic conditions suppress a biofilm-associated S. flexneri gene program induced by deoxycholate.

FIG 4.

FIG 4

Transcriptomic analysis of the effects of increased pH on deoxycholate-induced biofilms. (A) Top upregulated pathways from Shigella cultured in TSB with 0.05% NaDCA, compared to TSB only. (B) Top downregulated pathways from Shigella cultured in TSB with 0.05% NaDCA plus NaOH, compared to TSB with 0.05% NaDCA. (C) Heatmap showing selected genes involved in the arginine, leucine, and cysteine metabolism pathways. Data was row normalized by gene. n = 2 replicates/culture condition.

Basic conditions prevent induction of T3SS by deoxycholate.

In addition to stimulating biofilm formation, deoxycholate increases the expression of S. flexneri virulence factors, especially those related to the T3SS, the machinery S. flexneri utilizes to invade host cells (1). Given the attenuation of deoxycholate-induced biofilm formation under basic conditions, we hypothesized that adding NaOH could also reduce the virulence of S. flexneri. To test this, we utilized a Shigella strain that contains a fluorescent reporter for the T3SS (Shigella M90T Sm pTSAR 2.4) (25). In this system, mCherry is constitutively expressed in all bacteria but green fluorescent protein (GFP) is expressed only when the T3SS apparatus is induced. We first demonstrated that addition of 0.2% NaDCA in TSB induced GFP production in this Shigella reporter strain, whereas bacteria growing in TSB alone did not fluoresce green. When the pH of the TSB was adjusted upward with added NaOH, the T3SS activation by deoxycholate was reduced in a dose-dependent manner, with 5 and 10 mM concentrations of NaOH showing significant effects (Fig. 5A and B). This experiment further supports the model in which basic conditions deter Shigella from infection in the small intestine.

FIG 5.

FIG 5

Increased pH inhibits deoxycholate-induced virulence of Shigella. (A) Images showing the effects of NaDCA and NaOH on a fluorescent reporter of S. flexneri that expresses GFP upon activation of the T3SS (with constitutive expression of mCherry as an internal control). Scale bar = 100 μm. (B) Percentage of GFP-positive cells among mCherry-positive cells under increased NaOH concentrations, plotted as mean and standard deviation (n = 2 independent experiments). Statistical significance was determined by Student’s t tests. **, P < 0.01 with two-tailed Student's t test.

DISCUSSION

In this study, we utilized a series of in vitro bacterial assays, RNA sequencing, and fluorescence microscopy to demonstrate that alkalization decreases deoxycholate-regulated biofilm formation, which in turn decreases S. flexneri induction of virulence genes. These data call into question the assumption that the initial target of infecting Shigella is the small bowel. We propose, instead, that as S. flexneri transits through the distal small intestine, the basic pH of the luminal environment reduces biofilm formation, virulence, epithelial invasion, and host injury. As S. flexneri reaches the more acidic colonic lumen, bacterial biofilm formation is favored, and virulence-related gene expression facilitates epithelial invasion in this distal organ.

V. cholerae, a pathogen that preferentially colonizes the small intestine, offers an instructive contrast to Shigella. In both bacteria, bile salts induce biofilm formation (16). However, bicarbonate upregulates virulence factors and toxin production in V. cholerae, whereas the same condition reduces virulence in Shigella (13, 15). The clinical picture reflects the anatomic differences in pathology; cholera is characterized by watery diarrhea, and Shigella infections are often characterized by more distal symptoms and signs, such as tenesmus, rectal prolapse, hematochezia, and abundant fecal leukocytes. Thus, our data highlight the importance of biogeographic pathogenesis within the intestinal lumen.

Recent advances in the detection of intestinal pathogens using qPCR revealed that Shigella may be more prevalent than previously estimated (26). Antibiotics remain the only treatment for this infection (27), but resistance increasingly challenges case management. Thus, we urgently need to find alternative approaches to treat bacterial diseases like shigellosis (28). We propose a pH-dependent mechanism by which Shigella virulence is mediated. These data can form the basis for novel interventions to reduce virulence by targeting biofilm formation under basic pH conditions, to better manage shigellosis.

Bacterial biofilms play important roles in many biological systems. For example, Vibrio fischeri produces biofilms in the light organ of the Hawaiian squid, Pseudomonas aeruginosa produces biofilms in the lung airways, diminishing respiratory function, and Streptococcus mutans produces polymicrobial biofilms on the enamel surface of teeth, causing dental caries (23, 24, 29). Our data demonstrate that in Shigella biofilms, as in P. aeruginosa biofilms and V. fischeri biofilms, arginine and cysteine pathways accompany formation (30, 31). Our work may have implications beyond acute Shigella infections, as gut biofilms have been associated with colorectal cancer and inflammatory bowel disease, and may further the investigation of biofilms related to disorders of the gastrointestinal tract (32, 33).

Although more work is needed to further elucidate the pathways and host factors that control Shigella virulence and biofilm formation, our work expands on our knowledge of Shigella pathogenesis and provides a unique perspective on studying mechanisms of infection. This will prove to be imperative as we are slowly attempting to uncover more and more interactions between the host and pathogen.

MATERIALS AND METHODS

Biofilm formation assays.

Shigella flexneri strain 2a 2457T was purchased from ATCC (number 700930) and used within 6 months after receipt. S. flexneri was inoculated into LB medium from the original commercial stock and grown overnight at 37°C with shaking at 250 rpm. After this incubation, the bacteria were pelleted by centrifugation, resuspended in TSB, and measured by OD600. The bacterial suspension was then diluted with TSB and adjusted to an OD600 of 0.5. From this stock, the bacteria were further diluted 1:800 in TSB that included 0.05% NaDCA. The bacterial suspension was then added to a 96-well plate (180 µl/well). For experiments, 20 µl of H2O, diluted HCl, or diluted NaOH was added to each well to achieve the desired final concentrations. The plate was incubated under stationary conditions at 37°C for 24 h to allow biofilm formation. The supernatant above the resultant biofilm was removed and set aside for OD600 or CFU measurement; the biofilms were washed twice with 100 µl H2O and measured by OD600 before 100 µl of the MTT solution (0.5 mg/ml MTT in TSB) was added to the biofilms. The plate was incubated at 37°C for 10 min before the MTT solution was removed and dissolved with 100 µl dimethyl sulfoxide (DMSO). The OD570 of the resulting solution was measured with a Cytation 5 reader. The planktonic cells in the supernatant were sequentially diluted in phosphate-buffered saline (PBS) and plated on LB plates for CFU quantification. A similar procedure was utilized for the testing of NaHCO3 and NaCl and determination of the dose curve of NaDCA.

S. flexneri growth curve.

S. flexneri was grown overnight in LB medium. Bacteria were pelleted by centrifugation, reconstituted to an OD600 of 0.5, and then diluted 1:20 in TSB. The bacterial suspension was added to 96-well plates (180 µl/well), to which we then added H2O, HCl, or NaOH to a final volume of 200 µl. Plates were incubated at 37°C with shaking, and the OD600 of each well was measured at 2, 4, and 6 h. Doubling times were calculated from OD600 values at 2 and 4 h (see Table S2 in the supplemental material).

Biofilm dispersion assays.

An overnight culture of S. flexneri in LB medium was adjusted to an OD600 of 0.5 and further diluted 1:800 in TSB with 0.05% NaDCA. The diluted bacterial suspension was added to 96-well plates (200 µl/well) and incubated without shaking at 37°C for 24 h. After 24 h, the supernatant above the biofilm was removed, the biofilms were washed once with H2O (100 µl), and a new solution of TSB with various concentrations of NaOH or HCl (200 µl/well) was layered on top of the biofilms. After incubation at 37°C without shaking for 24 h, the resulting biofilms were measured by OD600 and MTT assay as described above.

RNA sequencing of S. flexneri.

The diluted solution of bacteria from an overnight culture (first adjusted to an OD600 of 0.5 and then diluted 1:20 in TSB) was further diluted to 1:800 in TSB with or without 0.05% NaDCA. For TSB-only control samples, an aliquot of 200 μl/well of the aforementioned dilutions (without NaDCA) was added to 96-well plates. To assess the effects of NaDCA and/or NaOH, an aliquot of 180 µl/well of the aforementioned dilutions (with NaDCA) was added with 20 µl of either H2O or 200 mM NaOH. The plates were incubated under stationary conditions at 37°C for 24 h. The planktonic bacteria in the wells containing TSB only (no NaDCA) or TSB with 0.05% NaDCA and 20 mM NaOH were collected, pelleted by centrifugation at 1300 g (15 min at 4°C), and lysed according to instructions for the RiboPure RNA purification kit for bacteria (Invitrogen). Biofilms from wells containing TSB and 0.05% NaDCA were washed and directly lysed with the same kit. RNA was then purified using the RNeasy minikit (Qiagen). Genomic DNA removal was performed according to the instructions for the Turbo DNA-free kit (Invitrogen).

Libraries were prepared according to the manufacturer’s protocol and sequenced with the Illumina HiSeq 3000 system. The Shigella flexneri 2a str. 2457T genome from Ensembl bacteria release 45 was used to align RNA sequencing reads with STAR v2.0.4b. Subread featureCounts v1.4.5 was used to derive gene counts. Gene counts were imported into and analyzed with the R/Bioconductor package EdgeR5 for normalization and then were imported into the R/Bioconductor package Limma. Differential expression was determined with the Benjamini-Hochberg procedure with false-discovery-rate-adjusted P values of ≤0.05. The PCA plot was made with the DDSeq2 package, based on all gene counts. Pathway analysis was performed by utilizing DAVID v6.7 (https://david.ncifcrf.gov).

For qPCR verification, 500 ng of RNA was converted to cDNA using the iScript reverse transcription supermix kit (Bio-Rad), and qPCR was performed with the TB Green Advantage qPCR premix. The recA gene was used as a housekeeping gene. The primers used are shown in Table S1 in the supplemental material.

Fluorescence microscopy to probe activation of T3SS.

A Congo red-positive colony of Shigella M90T Sm transformed with the pTSAR 2.4 plasmid (a gift from François-Xavier Campbell-Valois) was grown in TSB overnight. The strain was transformed as reported previously (25). The overnight culture was diluted 1:100 into TSB solutions with or without 0.2% NaDCA under various pH conditions (adjusted with H2O, HCl, or NaOH) and incubated for 3 h without shaking at 37°C. The activation of the T3SS was assessed with the GFP channel by fluorescence microscopy (25).

Data availability.

RNA sequencing data from this study was deposited in the NCBI GEO repository under accession number GSE183515.

ACKNOWLEDGMENTS

We thank François-Xavier Campbell-Valois for providing Shigella M90T Sm and pTSAR 2.4 plasmid. We also thank Shanshan Xiong for her help with this project.

I.-L.C. is supported by a fellowship for the MA/MD program from Washington University School of Medicine. The Crohn’s & Colitis Foundation also provided support through the Microbiome Initiative to T.S.S. B.D.M. is supported by Career Development Award 5IK2BX004909 from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service.

We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by Grant Number UL1 RR024992 from the NIH-National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.

The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NCRR, NIH, the U.S. Department of Veterans Affairs or the United States Government.

Footnotes

Supplemental material is available online only.

Supplemental file 1
Supplemental material. Download IAI.00387-21-s0001.pdf, PDF file, 1.1 MB (1.1MB, pdf)

Contributor Information

Thaddeus S. Stappenbeck, Email: stappet@ccf.org.

Igor E. Brodsky, University of Pennsylvania

REFERENCES

  • 1.Schroeder GN, Hilbi H. 2008. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 21:134–156. 10.1128/CMR.00032-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Khalil IA, Troeger C, Blacker BF, Rao PC, Brown A, Atherly DE, Brewer TG, Engmann CM, Houpt ER, Kang G, Kotloff KL, Levine MM, Luby SP, MacLennan CA, Pan WK, Pavlinac PB, Platts-Mills JA, Qadri F, Riddle MS, Ryan ET, Shoultz DA, Steele AD, Walson JL, Sanders JW, Mokdad AH, Murray CJL, Hay SI, Reiner RC, Jr.. 2018. Morbidity and mortality due to Shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016. Lancet Infect Dis 18:1229–1240. 10.1016/S1473-3099(18)30475-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.The HC, Thanh DP, Holt KE, Thomson NR, Baker S. 2016. The genomic signatures of Shigella evolution, adaptation and geographical spread. Nat Rev Microbiol 14:235–250. 10.1038/nrmicro.2016.10. [DOI] [PubMed] [Google Scholar]
  • 4.Arena ET, Campbell-Valois FX, Tinevez JY, Nigro G, Sachse M, Moya-Nilges M, Nothelfer K, Marteyn B, Shorte SL, Sansonetti PJ. 2015. Bioimage analysis of Shigella infection reveals targeting of colonic crypts. Proc Natl Acad Sci U S A 112:E3282–E3290. 10.1073/pnas.1509091112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jennison AV, Verma NK. 2004. Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiol Rev 28:43–58. 10.1016/j.femsre.2003.07.002. [DOI] [PubMed] [Google Scholar]
  • 6.Shim DH, Suzuki T, Chang SY, Park SM, Sansonetti PJ, Sasakawa C, Kweon MN. 2007. New animal model of shigellosis in the guinea pig: its usefulness for protective efficacy studies. J Immunol 178:2476–2482. 10.4049/jimmunol.178.4.2476. [DOI] [PubMed] [Google Scholar]
  • 7.Wassef JS, Keren DF, Mailloux JL. 1989. Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis. Infect Immun 57:858–863. 10.1128/iai.57.3.858-863.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Corr SC, Gahan CC, Hill C. 2008. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol 52:2–12. 10.1111/j.1574-695X.2007.00359.x. [DOI] [PubMed] [Google Scholar]
  • 9.Rout WR, Formal SB, Giannella RA, Dammin GJ. 1975. Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology 68:270–278. 10.1016/S0016-5085(75)80008-4. [DOI] [PubMed] [Google Scholar]
  • 10.Butler T, Speelman P, Kabir I, Banwell J. 1986. Colonic dysfunction during shigellosis. J Infect Dis 154:817–824. 10.1093/infdis/154.5.817. [DOI] [PubMed] [Google Scholar]
  • 11.Koestler BJ, Ward CM, Fisher CR, Rajan A, Maresso AW, Payne SM. 2019. Human intestinal enteroids as a model system of Shigella pathogenesis. Infect Immun 87:e00733-18. 10.1128/IAI.00733-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Begley M, Gahan CG, Hill C. 2005. The interaction between bacteria and bile. FEMS Microbiol Rev 29:625–651. 10.1016/j.femsre.2004.09.003. [DOI] [PubMed] [Google Scholar]
  • 13.Sistrunk JR, Nickerson KP, Chanin RB, Rasko DA, Faherty CS. 2016. Survival of the fittest: how bacterial pathogens utilize bile to enhance infection. Clin Microbiol Rev 29:819–836. 10.1128/CMR.00031-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pope LM, Reed KE, Payne SM. 1995. Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile salts. Infect Immun 63:3642–3648. 10.1128/iai.63.9.3642-3648.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nickerson KP, Chanin RB, Sistrunk JR, Rasko DA, Fink PJ, Barry EM, Nataro JP, Faherty CS. 2017. Analysis of Shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts. Infect Immun 85:e01067-16. 10.1128/IAI.01067-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hung DT, Zhu J, Sturtevant D, Mekalanos JJ. 2006. Bile acids stimulate biofilm formation in Vibrio cholerae. Mol Microbiol 59:193–201. 10.1111/j.1365-2958.2005.04846.x. [DOI] [PubMed] [Google Scholar]
  • 17.Ridlon JM, Kang DJ, Hylemon PB. 2006. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241–259. 10.1194/jlr.R500013-JLR200. [DOI] [PubMed] [Google Scholar]
  • 18.Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. 1988. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29:1035–1041. 10.1136/gut.29.8.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Koziolek M, Grimm M, Becker D, Iordanov V, Zou H, Shimizu J, Wanke C, Garbacz G, Weitschies W. 2015. Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap® system. J Pharm Sci 104:2855–2863. 10.1002/jps.24274. [DOI] [PubMed] [Google Scholar]
  • 20.Abuaita BH, Withey JH. 2009. Bicarbonate induces Vibrio cholerae virulence gene expression by enhancing ToxT activity. Infect Immun 77:4111–4120. 10.1128/IAI.00409-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Koestler BJ, Waters CM. 2014. Bile acids and bicarbonate inversely regulate intracellular cyclic di-GMP in Vibrio cholerae. Infect Immun 82:3002–3014. 10.1128/IAI.01664-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hubel KA. 1968. The ins and outs of bicarbonate in the alimentary tract. Gastroenterology 54:647–651. 10.1016/S0016-5085(68)80079-4. [DOI] [PubMed] [Google Scholar]
  • 23.He J, Hwang G, Liu Y, Gao L, Kilpatrick-Liverman L, Santarpia P, Zhou X, Koo H. 2016. l-Arginine modifies the exopolysaccharide matrix and thwarts Streptococcus mutans outgrowth within mixed-species oral biofilms. J Bacteriol 198:2651–2661. 10.1128/JB.00021-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hoiby N, Ciofu O, Bjarnsholt T. 2010. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5:1663–1674. 10.2217/fmb.10.125. [DOI] [PubMed] [Google Scholar]
  • 25.Campbell-Valois FX, Schnupf P, Nigro G, Sachse M, Sansonetti PJ, Parsot C. 2014. A fluorescent reporter reveals on/off regulation of the Shigella type III secretion apparatus during entry and cell-to-cell spread. Cell Host Microbe 15:177–189. 10.1016/j.chom.2014.01.005. [DOI] [PubMed] [Google Scholar]
  • 26.Lindsay B, Ochieng JB, Ikumapayi UN, Toure A, Ahmed D, Li S, Panchalingam S, Levine MM, Kotloff K, Rasko DA, Morris CR, Juma J, Fields BS, Dione M, Malle D, Becker SM, Houpt ER, Nataro JP, Sommerfelt H, Pop M, Oundo J, Antonio M, Hossain A, Tamboura B, Stine OC. 2013. Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries. J Clin Microbiol 51:1740–1746. 10.1128/JCM.02713-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Williams PCM, Berkley JA. 2018. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health 38(Suppl 1):S50–S65. 10.1080/20469047.2017.1409454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Puzari M, Sharma M, Chetia P. 2018. Emergence of antibiotic resistant Shigella species: a matter of concern. J Infect Public Health 11:451–454. 10.1016/j.jiph.2017.09.025. [DOI] [PubMed] [Google Scholar]
  • 29.Wolfe AJ, Millikan DS, Campbell JM, Visick KL. 2004. Vibrio fischeri σ54 controls motility, biofilm formation, luminescence, and colonization. Appl Environ Microbiol 70:2520–2524. 10.1128/AEM.70.4.2520-2524.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Singh P, Brooks JF, II, Ray VA, Mandel MJ, Visick KL. 2015. CysK plays a role in biofilm formation and colonization by Vibrio fischeri. Appl Environ Microbiol 81:5223–5234. 10.1128/AEM.00157-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Musken M, Di Fiore S, Dotsch A, Fischer R, Haussler S. 2010. Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology (Reading) 156:431–441. 10.1099/mic.0.033290-0. [DOI] [PubMed] [Google Scholar]
  • 32.Tomkovich S, Dejea CM, Winglee K, Drewes JL, Chung L, Housseau F, Pope JL, Gauthier J, Sun X, Muhlbauer M, Liu X, Fathi P, Anders RA, Besharati S, Perez-Chanona E, Yang Y, Ding H, Wu X, Wu S, White JR, Gharaibeh RZ, Fodor AA, Wang H, Pardoll DM, Jobin C, Sears CL. 2019. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. J Clin Invest 129:1699–1712. 10.1172/JCI124196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.McKenney PT, Yan J, Vaubourgeix J, Becattini S, Lampen N, Motzer A, Larson PJ, Dannaoui D, Fujisawa S, Xavier JB, Pamer EG. 2019. Intestinal bile acids induce a morphotype switch in vancomycin-resistant Enterococcus that facilitates intestinal colonization. Cell Host Microbe 25:695–705.e5. 10.1016/j.chom.2019.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1

Supplemental material. Download IAI.00387-21-s0001.pdf, PDF file, 1.1 MB (1.1MB, pdf)

Data Availability Statement

RNA sequencing data from this study was deposited in the NCBI GEO repository under accession number GSE183515.


Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES